Organotellurium and organoselenium compounds attenuate Mn-induced toxicity in Caenorhabditis elegans by preventing oxidative stress

Free Radical Biology and Medicine

Volumn 52, Issue 9, 2012, Pages 1903-1910

  Avila, Daiana Silva ^a,b   Benedetto, Alexandre ^c   Au, Catherine ^c   Manarin, Flávia ^d   Erikson, Keith ^e   Soares, Felix Antunes ^d   Rocha, João Batista Teixeira ^d   Aschner, Michael ^b  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^e UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Caenorhabditis elegans; FOXO; Free radicals; Manganese; Organochalcogens; Oxidative stress; Selenium; Tellurium; Toxicity

Indexed keywords

ANTIOXIDANT; DIETHYL 2 PHENYL 2 TELLUROPHENYL VINYL PHOSPHONATE; DIPHENYL DITELLURIDE; EBSELEN; MANGANESE; ORGANOSELENIUM DERIVATIVE; ORGANOTELLURIUM DERIVATIVE; TRANSCRIPTION FACTOR DAF 16; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; LIFESPAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TRANSPORT; SURVIVAL RATE; WORM;

CAENORHABDITIS ELEGANS; MAMMALIA; MUS;

EID: 84984535652     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.02.044     Document Type: Article

References (52)

1. C.W. Nogueira, G. Zeni, and J.B. Rocha Organoselenium and organotellurium compounds: toxicology and pharmacology Chem. Rev. 104 2004 6255 6285
2. L.A. Ba, M. Doring, V. Jamier, and C. Jacob Tellurium: an element with great biological potency and potential Org. Biomol. Chem. 8 2010 4203 4216
3. G. Zeni, D.S. Ludtke, R.B. Panatieri, and A.L. Braga Vinylic tellurides: from preparation to their applicability in organic synthesis Chem. Rev. 106 2006 1032 1076
4. D.S. Avila, D. Colle, P. Gubert, A.S. Palma, G. Puntel, F. Manarin, S. Noremberg, P.C. Nascimento, M. Aschner, J.B. Rocha, and F.A. Soares A possible neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity Toxicol. Sci. 115 2010 194 201
5. H. Imai, D.I. Graham, H. Masayasu, and I.M. Macrae Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia Free Radic. Biol. Med. 34 2003 56 63
6. R.P. Ineu, M.E. Pereira, M. Aschner, C.W. Nogueira, G. Zeni, and J.B. Rocha Diphenyl diselenide reverses gastric lesions in rats: involvement of oxidative stress Food Chem. Toxicol. 46 2008 3023 3029
7. C.R. Jesse, L. Savegnago, and C.W. Nogueira Mechanisms involved in the antinociceptive and anti-inflammatory effects of bis selenide in mice J. Pharm. Pharmacol. 61 2009 623 630
8. K. Briviba, R. Tamler, L.O. Klotz, L. Engman, I.A. Cotgreave, and H. Sies Protection by organotellurium compounds against peroxynitrite-mediated oxidation and nitration reactions Biochem. Pharmacol. 55 1998 817 823
9. L. Engman, T. Kandra, A. Gallegos, R. Williams, and G. Powis Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells Anticancer Drug Des. 15 2000 323 330
10. G. Scambia, P.B. Panici, F. Battaglia, G. Ferrandina, C. Gaggini, and S. Mancuso Growth inhibitory effect of diheptyl diselenide on various human cancer cell lines Anticancer Res. 9 1989 1697 1699
11. T. Posser, M.T. de Paula, J.L. Franco, R.B. Leal, and J.B. da Rocha Diphenyl diselenide induces apoptotic cell death and modulates ERK1/2 phosphorylation in human neuroblastoma SH-SY5Y cells Arch. Toxicol. 85 2011 645 651
12. M. Chalfie, Y. Tu, G. Euskirchen, W.W. Ward, and D.C. Prasher Green fluorescent protein as a marker for gene expression Science 263 1994 802 805
13. M.B. Gerstein, Z.J. Lu, E.L. Van Nostrand, C. Cheng, B.I. Arshinoff, T. Liu, K.Y. Yip, R. Robilotto, A. Rechtsteiner, K. Ikegami, P. Alves, A. Chateigner, M. Perry, M. Morris, R.K. Auerbach, X. Feng, J. Leng, A. Vielle, W. Niu, K. Rhrissorrakrai, A. Agarwal, R.P. Alexander, G. Barber, C.M. Brdlik, J. Brennan, J.J. Brouillet, A. Carr, M.S. Cheung, H. Clawson, S. Contrino, L.O. Dannenberg, A.F. Dernburg, A. Desai, L. Dick, A.C. Dose, J. Du, T. Egelhofer, S. Ercan, G. Euskirchen, B. Ewing, E.A. Feingold, R. Gassmann, P.J. Good, P. Green, F. Gullier, M. Gutwein, M.S. Guyer, L. Habegger, T. Han, J.G. Henikoff, S.R. Henz, A. Hinrichs, H. Holster, T. Hyman, A.L. Iniguez, J. Janette, M. Jensen, M. Kato, W.J. Kent, E. Kephart, V. Khivansara, E. Khurana, J.K. Kim, P. Kolasinska-Zwierz, E.C. Lai, I. Latorre, A. Leahey, S. Lewis, P. Lloyd, L. Lochovsky, R.F. Lowdon, Y. Lubling, R. Lyne, M. MacCoss, S.D. Mackowiak, M. Mangone, S. McKay, D. Mecenas, G. Merrihew, D.M. Miller III, A. Muroyama, J.I. Murray, S.L. Ooi, H. Pham, T. Phippen, E.A. Preston, N. Rajewsky, G. Ratsch, H. Rosenbaum, J. Rozowsky, K. Rutherford, P. Ruzanov, M. Sarov, R. Sasidharan, A. Sboner, P. Scheid, E. Segal, H. Shin, C. Shou, F.J. Slack, C. Slightam, R. Smith, W.C. Spencer, E.O. Stinson, S. Taing, T. Takasaki, D. Vafeados, K. Voronina, G. Wang, N.L. Washington, C.M. Whittle, B. Wu, K.K. Yan, G. Zeller, Z. Zha, M. Zhong, X. Zhou, J. Ahringer, S. Strome, K.C. Gunsalus, G. Micklem, X.S. Liu, V. Reinke, S.K. Kim, L.W. Hillier, S. Henikoff, F. Piano, M. Snyder, L. Stein, J.D. Lieb, and R.H. Waterston Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project Science 330 2010 1775 1787
14. K.J. Helmcke, D.S. Avila, and M. Aschner Utility of Caenorhabditis elegans in high throughput neurotoxicological research Neurotoxicol. Teratol. 32 2010 62 67
15. R.T. Peterson, R. Nass, W.A. Boyd, J.H. Freedman, K. Dong, and T. Narahashi Use of non-mammalian alternative models for neurotoxicological study Neurotoxicology 29 2008 546 555
16. A. Benedetto, C. Au, D.S. Avila, D. Milatovic, and M. Aschner Extracellular dopamine potentiates Mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans PLoS Genet. 6 2010
17. R. Settivari, J. Levora, and R. Nass The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in Caenorhabditis elegans models of manganism and Parkinson disease J. Biol. Chem. 284 2009 35758 35768
18. R. Baumeister, E. Schaffitzel, and M. Hertweck Endocrine signaling in Caenorhabditis elegans controls stress response and longevity J. Endocrinol. 190 2006 191 202
19. S.S. Lee, S. Kennedy, A.C. Tolonen, and G. Ruvkun DAF-16 target genes that control C. elegans life-span and metabolism Science 300 2003 644 647
20. C.T. Murphy The search for DAF-16/FOXO transcriptional targets: approaches and discoveries Exp. Gerontol. 41 2006 910 921
21. A.L. Braga, E.F. Alves, C.C. Silveira, and L.H. Andrade Stereoselective addition of sodium organyl chalcogenolates to alkynylphosphonates: synthesis of diethyl 2-(organyl)-2-(organochalcogenyl)vinylphosphonates Tetrahedron Lett. 41 2000 161 163
22. W.S. Haller, and K.J. Irgolic Diaryl ditellurides from Grignard-reagents and elemental tellurium J. Organomet. Chem. 39 1972 97 101
23. C. Paulmier Selenoorganic functional groups C. Paulmier, Selenium Reagents and Intermediates in Organic Synthesis 1986 Pergamon Press Oxford
24. S. Brenner The genetics of Caenorhabditis elegans Genetics 77 1974 71 94
25. T. Stiernagle Maintenance of C. elegans I.A. Hope, C. elegans: a Practical Approach 1999 Oxford Univ. Press New York
26. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
27. D.S. de Avila, M.C. Beque, V. Folmer, A.L. Braga, G. Zeni, C.W. Nogueira, F.A. Soares, and J.B. Rocha Diethyl 2-phenyl-2 tellurophenyl vinylphosphonate: an organotellurium compound with low toxicity Toxicology 224 2006 100 107
28. J.C. Schafer, M.E. Winkelbauer, C.L. Williams, C.J. Haycraft, R.A. Desmond, and B.K. Yoder IFTA-2 is a conserved cilia protein involved in pathways regulating longevity and dauer formation in Caenorhabditis elegans J. Cell Sci. 119 2006 4088 4100
29. B. Halliwell, J.M. Gutteridge, and C.E. Cross Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med. 119 1992 598 620
30. T. Toda, M. Nakamura, H. Morisawa, M. Hirota, R. Nishigaki, and Y. Yoshimi Proteomic approaches to oxidative protein modifications implicated in the mechanism of aging Geriatr. Gerontol. Int. 10 Suppl. 1 2010 S25 31
31. S.O. Simmons, C.Y. Fan, and R. Ramabhadran Cellular stress response pathway system as a sentinel ensemble in toxicological screening Toxicol. Sci. 111 2009 202 225
32. L. Engman, N. Al-Maharik, M. McNaughton, A. Birmingham, and G. Powis Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells Bioorg. Med. Chem. 11 2003 5091 5100
33. M. Parnham, and H. Sies Ebselen: prospective therapy for cerebral ischaemia Expert Opin. Investig. Drugs 9 2000 607 619
34. H. Sies, and G.E. Arteel Interaction of peroxynitrite with selenoproteins and glutathione peroxidase mimics Free Radic. Biol. Med. 28 2000 1451 1455
35. B.K. Sarma, and G. Mugesh Antioxidant activity of the anti-inflammatory compound ebselen: a reversible cyclization pathway via selenenic and seleninic acid intermediates Chemistry 14 2008 10603 10614
36. A. Sausen de Freitas, A. de Souza Prestes, C. Wagner, J. Haigert Sudati, D. Alves, L. Oliveira Porciuncula, I.J. Kade, and J.B. Teixeira Rocha Reduction of diphenyl =diselenide and analogs by mammalian thioredoxin reductase is independent of their glutathione peroxidase-like activity: a possible novel pathway for their antioxidant activity Molecules 15 2010 7699 7714
37. T. Yamaguchi, K. Sano, K. Takakura, I. Saito, Y. Shinohara, T. Asano, and H. Yasuhara Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial: Ebselen Study Group Stroke 29 1998 12 17
38. A. Ogawa, T. Yoshimoto, H. Kikuchi, K. Sano, I. Saito, T. Yamaguchi, and H. Yasuhara Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial Cerebrovasc. Dis. 9 1999 112 118
39. I. Saito, T. Asano, K. Sano, K. Takakura, H. Abe, T. Yoshimoto, H. Kikuchi, T. Ohta, and S. Ishibashi Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage Neurosurgery 42 1998 269 277 discussion 277-268
40. D.S. Avila, P. Gubert, C.L. Dalla Corte, D. Alves, C.W. Nogueira, J.B. Rocha, and F.A. Soares A biochemical and toxicological study with diethyl 2-phenyl-2-tellurophenyl vinylphosphonate in a sub-chronic intraperitoneal treatment in mice Life Sci. 80 2007 1865 1872
41. D.S. Avila, P. Gubert, A. Palma, D. Colle, D. Alves, C.W. Nogueira, J.B. Rocha, and F.A. Soares An organotellurium compound with antioxidant activity against excitotoxic agents without neurotoxic effects in brain of rats Brain Res. Bull. 76 2008 114 123
42. V.B. Brito, J.B. Rocha, V. Folmer, and F. Erthal Diphenyl diselenide and diphenyl ditelluride increase the latency for 4-aminopyridine-induced chemical seizure and prevent death in mice Acta Biochim. Pol. 56 2009 125 134
43. M. Aschner, K.M. Erikson, E. Herrero Hernandez, and R. Tjalkens Manganese and its role in Parkinson's disease: from transport to neuropathology Neuromolecular Med. 11 2009 252 266
44. A. Benedetto, C. Au, and M. Aschner Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease Chem. Rev. 109 2009 4862 4884
45. R. Graumann, I. Paris, P. Martinez-Alvarado, P. Rumanque, C. Perez-Pastene, S.P. Cardenas, P. Marin, F. Diaz-Grez, R. Caviedes, P. Caviedes, and J. Segura-Aguilar Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease: possible neuroprotective role of DT-diaphorase Pol. J. Pharmacol. 54 2002 573 579
46. C. Au, A. Benedetto, J. Anderson, A. Labrousse, K. Erikson, J.J. Ewbank, and M. Aschner SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans PLoS One 4 2009 e7792
47. J. Xiao, Q. Rui, Y. Guo, X. Chang, and D. Wang Prolonged manganese exposure induces severe deficits in lifespan, development and reproduction possibly by altering oxidative stress response in Caenorhabditis elegans J. Environ. Sci. (China) 21 2009 842 848
48. L. Zhang, G. Jie, J. Zhang, and B. Zhao Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress Free Radic. Biol. Med. 46 2009 414 421
49. T.M. Bass, D. Weinkove, K. Houthoofd, D. Gems, and L. Partridge Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans Mech. Ageing Dev. 128 2007 546 552
50. M. Tatar, A. Bartke, and A. Antebi The endocrine regulation of aging by insulin-like signals Science 299 2003 1346 1351
51. J.M. Tullet, M. Hertweck, J.H. An, J. Baker, J.Y. Hwang, S. Liu, R.P. Oliveira, R. Baumeister, and T.K. Blackwell Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans Cell 132 2008 1025 1038
52. H.A. Wetli, P.D. Buckett, and M. Wessling-Resnick Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake Chem. Biol. 13 2006 965 972